FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

6 results

axtle
(pemetrexed)
Avyxa Pharma, LLC
Usage: AXTLE is indicated for the treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with cisplatin, maintenance therapy after prior chemotherapy, and for recurrent NSCLC. It also treats unresectable malignant pleural mesothelioma in combination with cisplatin. Not for squamous NSCLC.
pemetrexed
(PEMETREXED DISODIUM)
Fresenius Kabi USA, LLC
Usage: Pemetrexed for injection is indicated for the treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy, as maintenance therapy, and for recurrent cases. Additionally, it is used with cisplatin for unresectable malignant pleural mesothelioma. Not for squamous cell NSCLC.
pemetrexed
(Pemetrexed disodium)
NorthStar RxLLC
Usage: Pemetrexed for Injection is indicated for the treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy, for maintenance therapy, and for recurrent NSCLC post-chemotherapy. It is also indicated for malignant pleural mesothelioma in combination with cisplatin. Not for squamous cell NSCLC.
pemetrexed
(Pemetrexed)
Teva Pharmaceuticals Inc
Usage: Pemetrexed Injection is indicated for the treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) in combination with pembrolizumab or cisplatin, and for maintenance or recurrent NSCLC. It is also used with cisplatin for unresectable malignant pleural mesothelioma. Not indicated for squamous NSCLC.
pemetrexed dipotassium
(pemetrexed dipotassium)
Avyxa Pharma, LLC
Usage: Pemetrexed for Injection is indicated for the treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with cisplatin, as maintenance therapy, or for recurrent NSCLC. It is also indicated with cisplatin for malignant pleural mesothelioma when the disease is unresectable or surgery is not an option.
pemetrexed disodium
(Pemetrexed)
Amneal Pharmaceuticals LLC
Usage: Pemetrexed for injection is indicated for the initial treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy or as a maintenance therapy post-chemotherapy. It is also indicated, with cisplatin, for treating unresectable malignant pleural mesothelioma. Not for use in squamous cell NSCLC.

Medications for Mesothelioma Malignant

axtle

pemetrexed

pemetrexed

pemetrexed

pemetrexed dipotassium

pemetrexed disodium